Cited by 784Pain Management and Placebo EffectPsychosomatic Disorders and Their TreatmentsPharmacovigilance and Adverse Drug Reactions

The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.

Nonspecific Medication Side Effects and the Nocebo Phenomenon

Open access

Barsky, Arthur J.·2002·JAMA

DOI 10.1001/jama.287.5.622

Open this paper in CoChat — free account

Abstract

Patients taking active medications frequently experience adverse, nonspecific side effects that are not a direct result of the specific pharmacological action of the drug. Although this phenomenon is common, distressing, and costly, it is rarely studied and poorly understood. The nocebo phenomenon, in which placebos produce adverse side effects, offers some insight into nonspecific side effect reporting. We performed a focused review of the literature, which identified several factors that appear to be associated with the nocebo phenomenon and/or reporting of nonspecific side effects while taking active medication: the patient's expectations of adverse effects at the outset of treatment; a process of conditioning in which the patient learns from prior experiences to associate medication-taking with somatic symptoms; certain psychological characteristics such as anxiety, depression, and the tendency to somatize; and situational and contextual factors. Physicians and other health care personnel can attempt to ameliorate nonspecific side effects to active medications by identifying in advance those patients most at risk for developing them and by using a collaborative relationship with the patient to explain and help the patient to understand and tolerate these bothersome but nonharmful symptoms.

Integrity signals

Registry

Crossref · 10.1001/jama.287.5.622

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Psychology of Physical Symptoms
Pennebaker, J. W. (1982) · Springer eBooks · doi:10.1007/978-1-4613-8196-9 · Cited by 1,789
Functional Somatic Syndromes
BARSKY, A. J., & Borus, J. F. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-11-199906010-00016 · Cited by 964
Self-citation
Drug-related morbidity and mortality. A cost-of-illness model
Johnson, J. A. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.18.1949 · Cited by 942
The Importance of Placebo Effects in Pain Treatment and Research
Turner, J. A. (1994) · JAMA · doi:10.1001/jama.1994.03510440069036 · Cited by 871
The Role of Medication Noncompliance and Adverse Drug Reactions in Hospitalizations of the Elderly
Col, N. F. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390160093019 · Cited by 765
Drug-Related Hospital Admissions
Einarson, T. R. (1993) · Annals of Pharmacotherapy · doi:10.1177/106002809302700702 · Cited by 520
Adequacy and Duration of Antidepressant Treatment in Primary Care
Katon, W. J., Korff, M. V., Lin, E. H. B., Bush, T. M., & Ormel, J. (1992) · Medical Care · doi:10.1097/00005650-199201000-00007 · Cited by 519
Frequency and cost of serious adverse drug reactions in a department of general medicine
Moore, N. D., Lecointre, D., Noblet, C., & Mabille, M. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00667.x · Cited by 322
Morphine Analgesic Tolerance: Its Situation Specificity Supports a Pavlovian Conditioning Model
Siegel, S. (1976) · Science · doi:10.1126/science.935870 · Cited by 318
Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness
de Craen, A. J. M., Roos, P., de Vries, A. L., & Kleijnen, J. (1996) · BMJ · doi:10.1136/bmj.313.7072.1624 · Cited by 313

Show all 69 references

Sorted by citations

Items 301–400 of 783

Nocebo in motor neuron disease: systematic review and meta-analysis of placebo-controlled clinical trials
Shafiq, F., Mitsikostas, D. D., & Zis, P. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1335325 · Cited by 22
Experimental Assessment of Nocebo Effects and Nocebo Side Effects: Definitions, Study Design, and Implications for Psychiatry and Beyond
Faasse, K., Helfer, S. G., Barnes, K., Colagiuri, B., & Geers, A. L. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00396 · Cited by 22
Psychometric Properties of the Fear of Progression Questionnaire for Children (FoP-Q-SF/C)
Luz, J. K., Martini, J., Clever, K., Herschbach, P., Christiansen, H., & Schepper, F. (2020) · Klinische Pädiatrie · doi:10.1055/a-1128-0471 · Cited by 23
Pain experience and mood disorders during the lockdown of the COVID-19 pandemic in the United States: an opportunistic study
Colloca, L., Thomas, S., Yin, M., Haycock, N. R., & Wang, Y. (2021) · PAIN Reports · doi:10.1097/pr9.0000000000000958 · Cited by 24
Impact of media coverage on side effect reports from the COVID-19 vaccine
MacKrill, K. (2022) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2022.111093 · Cited by 23
The Role of Patients’ Response Expectancies in Side Effect Development and Control
Roscoe, J. A., Jean‐Pierre, P., Shelke, A. R., Kaufman, M. E., Bole, C. W., & Morrow, G. R. (2006) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2005.12.001 · Cited by 23
When symptoms become side effects: Development of the side effect attribution scale (SEAS)
MacKrill, K., Webster, R., Rubin, G. J., Witthöft, M., Silvester, C., Emad, Y., & Petrie, K. J. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110340 · Cited by 21
Effects of Patients’ Expectation in Dermatology: Evidence from Experimental and Clinical Placebo Studies and Implications for Dermatologic Practice and Research
Sondermann, W., Jockenhöfer, F., Dissemond, J., Pfaar, O., Bingel, U., & Schedlowski, M. (2021) · Dermatology · doi:10.1159/000513445 · Cited by 22
Possible alleviation of symptoms and side effects through clinicians’ nocebo information and empathy in an experimental video vignette study
Meijers, M. C., Stouthard, J. M., Evers, A. W. M., Das, E. H. H. J., Drooger, H. J., Jansen, S. J. A. J., Francke, A. L., Plum, N., van der Wall, E., Nestoriuc, Y., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-19729-w · Cited by 21
Effects of information and 50 Hz magnetic fields on cognitive performance and reported symptoms
Nevelsteen, S., Legros, J., & Crasson, M. (2007) · Bioelectromagnetics · doi:10.1002/bem.20265 · Cited by 22
Attitudes toward psychopharmacology among hospitalized patients from diverse ethno-cultural backgrounds
Thorens, G., Gex‐Fabry, M., ZULLINO, D. F., & Eytan, A. (2008) · BMC Psychiatry · doi:10.1186/1471-244x-8-55 · Cited by 21
‘Just Breathe Normally’
Schenk, P. W. (2008) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000312257.41249.65 · Cited by 21
Frequency of Symptomatic Adverse Events in Rheumatoid Arthritis: An Exploratory Online Survey
Hazlewood, G. S., Schieir, O., Bykerk, V. P., Kamso, M. M., Tugwell, P., Wells, G. A., Richards, D. P., Proulx, L., Hull, P. M., & Bartlett, S. J. (2022) · The Journal of Rheumatology · doi:10.3899/jrheum.210688 · Cited by 20
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial
Harris, V. C., Holmes, J., Gbinigie, O. A., Rahman, N. M., Richards, D. B., Hayward, G., Dorward, J., Lowe, D. M., Standing, J. F., Breuer, J., et al. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00431-6 · Cited by 21
Understanding the Placebo Effect: Part 2: Underlying Psychological & Neurobiological Processes
Howland, R. H. (2008) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20080601-05 · Cited by 20
Somatization is Associated With Non-Adherence to Opioid Prescriptions
Trafton, J. A., Cucciare, M. A., Lewis, E. T., & Oser, M. L. (2011) · Journal of Pain · doi:10.1016/j.jpain.2010.11.002 · Cited by 20
Use of Placebos in Pain Management
Arnstein, P. M., Broglio, K., Wuhrman, E., & Kean, M. B. (2011) · Pain Management Nursing · doi:10.1016/j.pmn.2010.10.033 · Cited by 20
Nationwide Survey of Subjectively Reported Adverse Drug Reactions in Sweden
Isacson, D. G. L., Johansson, L., & Bingefors, K. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1k488 · Cited by 20
Nocebo in chronic inflammatory demyelinating polyneuropathy; a systematic review and meta-analysis of placebo-controlled clinical trials
Zis, P., Hadjivassiliou, M., Sarrigiannis, P. G., Jenkins, T. M., & Mitsikostas, D. D. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.03.009 · Cited by 20
Assessment of adverse events in clinical drug trials: Identifying amitriptyline’s placebo- and baseline-controlled side effects.
Rheker, J., Rief, W., Doering, B. K., & Winkler, A. (2018) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000194 · Cited by 20
Are Patients With Schizophrenia Spectrum Disorders More Prone to Manifest Nocebo-Like-Effects? A Meta-Analysis of Adverse Events in Placebo Groups of Double-Blind Antipsychotic Trials
Palermo, S., Giovannelli, F., Bartoli, M., & Amanzio, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00502 · Cited by 22
The Role Of Effective Radiation Therapist–Patient Communication In Alleviating Treatment-Related Pain And Procedural Discomfort During Radiotherapy
Mattarozzi, K., Fino, E., Panni, V., Agostini, A., MORGANTI, A. G., & Russo, P. M. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s214375 · Cited by 20
Neuroticism, Side Effects, and Health Perceptions Among HIV-Infected Individuals on Antiretroviral Medications
Johnson, M. O., & Neilands, T. B. (2007) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-007-9056-9 · Cited by 21
PRELIMINARY STUDY OF A SCALE MEASURING DEPRESSION AND SOMATIC SYMPTOMS
Hung, C., Su, Y., Weng, L., & Liu, C.-Y. (2006) · Psychological Reports · doi:10.2466/pr0.99.2.379-389 · Cited by 20
Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorder
Papakostas, G. I., Petersen, T., Hughes, M. E., Nierenberg, A. A., Alpert, J. E., & D, M. F. M. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.02.007 · Cited by 20
Longitudinal trends and determinants of patient-reported side effects on ART–a Swedish national registry study
Mellgren, Å., Eriksson, L. E., Reinius, M., Marrone, G., & Svedhem, V. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242710 · Cited by 19
The emotive impact of medical language
Vranceanu, A., Elbon, M., Adams, M., & Ring, D. (2012) · Hand · doi:10.1007/s11552-012-9419-z · Cited by 19
Nocebo responses to high-voltage power lines: Evidence from a prospective field study
Porsius, J. T., Claassen, L., Woudenberg, F., Smid, T., & Timmermans, D. R. M. (2015) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2015.11.038 · Cited by 19
Physicians’ beliefs about placebo and nocebo effects in antidepressants – an online survey among German practitioners
Kampermann, L., Nestoriuc, Y., & Mora, M. C. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178719 · Cited by 18
Sharing clinical notes, and placebo and nocebo effects: Can documentation affect patient health?
Blease, C., Delbanco, T., Torous, J. B., Pontén, M., DesRoches, C. M., Hägglund, M., Walker, J., & Kirsch, I. (2020) · Journal of Health Psychology · doi:10.1177/1359105320948588 · Cited by 18
Exploring the opinions and experiences of patients with generic substitution: a representative study of Polish society
Drozdowska, A., & Hermanowski, T. (2014) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-014-0041-8 · Cited by 19
Nocebo effect in Dermatology
Sonthalia, S., Sahaya, K., Singal, A., Gupta, K., Srivastava, A., Wadhawan, R., Zartab, H., & Arora, R. (2015) · Indian Journal of Dermatology Venereology and Leprology · doi:10.4103/0378-6323.155573 · Cited by 19
Use of generic medicines in Latvia: awareness, opinions and experiences of the population
Salmane-Kuļikovska, I., Poplavska, E., Ceha, M., & Mežinska, S. (2019) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-018-0159-5 · Cited by 19
Study Design Affects Participant Expectations
Rutherford, B. R., Rose, S. A., Sneed, J. R., & Roose, S. P. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31819a9181 · Cited by 19
Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women
van Oortmerssen, J. A. E., Mulder, J. W. C. M., van der Bijl, M. F., Mijnster, R. J. M., Kavousi, M., & van Lennep, J. E. R. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01275-1 · Cited by 19
Really just a little prick? A meta-analysis on adverse events in placebo control groups of seasonal influenza vaccination RCTs
Bender, F. L., Rief, W., & Wilhelm, M. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.11.033 · Cited by 18
Managing hypercholesterolemia in adults older than 75 years without a history of atherosclerotic cardiovascular disease: An Expert Clinical Consensus from the National Lipid Association and the American Geriatrics Society
Bittner, V., Linnebur, S. A., Dixon, D. L., Forman, D. E., Green, A. R., Jacobson, T. A., Orkaby, A. R., Saseen, J. J., & Virani, S. S. (2025) · Journal of clinical lipidology · doi:10.1016/j.jacl.2024.09.005 · Cited by 20
Lessons to be Learned from Placebo Arms in Psychopharmacology Trials
Doering, B. K., Rief, W., & Petrie, K. J. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-44519-8_15 · Cited by 18
Conscientiousness is modified by genetic variation in catechol‐O‐methyltransferase to reduce symptom complaints in IBS patients
Hall, K. T., Tolkin, B. R., Chinn, G. M., Kirsch, I., Kelley, J. M., Lembo, A. J., Kaptchuk, T. J., Kokkotou, E. G., Davis, R. B., & Conboy, L. A. (2014) · Brain and Behavior · doi:10.1002/brb3.294 · Cited by 18
Why current drug adherence programs fail
Arlt, A. D., Nestoriuc, Y., & Rief, W. (2017) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000345 · Cited by 18
How do nocebo effects in placebo groups of randomized controlled trials provide a possible explicative framework for the COVID-19 pandemic?
Amanzio, M., Cipriani, G. E., & Bartoli, M. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1900728 · Cited by 16
Placebos and Neurofeedback: A Case for Facilitating and Maximizing Placebo Response in Neurofeedback Treatments
Hammond, D. C. (2011) · Journal of Neurotherapy · doi:10.1080/10874208.2011.570694 · Cited by 19
The effects of Ginkgo biloba extract (LI 1370) supplementation and discontinuation on activities of daily living and mood in free living older volunteers
Trick, L., Boyle, J., & Hindmarch, I. (2004) · Phytotherapy Research · doi:10.1002/ptr.1479 · Cited by 18
Explaining all without causing unnecessary harm: Is there scope for positively framing medical risk information?
Webster, R., Weinman, J. A., & Rubin, G. J. (2018) · Patient Education and Counseling · doi:10.1016/j.pec.2018.09.014 · Cited by 18
Klinische Bedeutung des Placeboeffektes
Oeltjenbruns, J., & Schäfer, M. (2008) · Der Anaesthesist · doi:10.1007/s00101-008-1370-6 · Cited by 18
Placebo
Breidert, M., & Hofbauer, K. G. (2009) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2009.0751 · Cited by 20
Students’ psychophysiological reactivity to trigger warnings
Bruce, M. J., Stasik-O’Brien, S. M., & Hoffmann, H. (2021) · Current Psychology · doi:10.1007/s12144-021-01895-1 · Cited by 19
The effect of social learning on the nocebo effect: a systematic review and meta-analysis with recommendations for the future
Saunders, C., Tan, W., Faasse, K., Colagiuri, B., Sharpe, L., & Barnes, K. (2024) · Health Psychology Review · doi:10.1080/17437199.2024.2394682 · Cited by 17
Exploring factors associated with patients’ adherence to antihypertensive drugs among people with primary hypertension in the United Kingdom
Kurdi, A. B., Chen, L., & Elliott, R. A. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001382 · Cited by 17
Nocebo Effect in Menière's Disease: A Meta-analysis of Placebo-controlled Randomized Controlled Trials
Dimitriadis, P. A., & Zis, P. (2017) · Otology & Neurotology · doi:10.1097/mao.0000000000001555 · Cited by 17
Using Learning Strategies to Inhibit the Nocebo Effect
Quinn, V. F., & Colagiuri, B. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.01.011 · Cited by 16
Increasing and dampening the nocebo response following medicine-taking: A randomised controlled trial
MacKrill, K., Morrison, Z., & Petrie, K. J. (2021) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2021.110630 · Cited by 19
The Potential of a Placebo/Nocebo Effect in Pharmacogenetics
Haga, S. B., Warner, L., & O’Daniel, J. M. (2009) · Public Health Genomics · doi:10.1159/000189628 · Cited by 20
Classical and new proving methodology: Provings of Plumbum metallicum and Piper methysticum and comparison with a classical proving of Plumbum metallicum
Signorini, A. M., Lubrano, A., Manuele, G., Fagone, G., Vittorini, C., Boso, F., Vianello, P., Rebuffi, A., Frongia, T., Rocco, V., et al. (2005) · Homeopathy · doi:10.1016/j.homp.2005.02.009 · Cited by 17
Depression in Women With Inflammatory Bowel Disease: A Multifaceted Approach for a Multidimensional Problem
Bommena, S., Goldberg, A., Amini, M., & Alishahi, Y. (2022) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izac245 · Cited by 16
Headaches and the Nocebo Effect
Evans, R. W., & Rogers, M. P. (2003) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2003.03216.x · Cited by 16
Study protocol for statin web-based investigation of side effects (StatinWISE): a series of randomised controlled N-of-1 trials comparing atorvastatin and placebo in UK primary care
Herrett, E. L., Williamson, E., Beaumont, D., Prowse, D., Youssouf, N. F., Brack, K. E., Armitage, J., Goldacre, B. M., MacDonald, T. M., van Staa, T. P., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016604 · Cited by 16
Common CYP2D6, CYP2C9, and CYP2C19 Gene Variants, Health Anxiety, and Neuroticism Are Not Associated With Self-Reported Antidepressant Side Effects
Maggo, S. D. S., Kennedy, M. A., Barczyk, Z. A., Miller, A. L., Rucklidge, J. J., Mulder, R., & Foulds, J. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01199 · Cited by 20
Nocebo effects on motor performance: A systematic literature review
Horváth, Á., Köteles, F. G., & Szabó, A. (2021) · Scandinavian Journal of Psychology · doi:10.1111/sjop.12753 · Cited by 17
Learned Nocebo Effects on Cutaneous Sensations of Pain and Itch: A Systematic Review and Meta-analysis of Experimental Behavioral Studies on Healthy Humans
Thomaidou, M. A., Blythe, J. S., Peerdeman, K. J., van Laarhoven, A. I. M., van Schothorst, M. M. E., Veldhuijzen, D. S., & Evers, A. W. M. (2023) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001194 · Cited by 15
The effects of psychopathology on subjective experience of side effects of antipsychotics in patients with schizophrenia
Hwang, S. S., Jung, D. C., Ahn, Y. M., Kim, S. H., & Kim, Y. S. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328334e5a8 · Cited by 16
Do we Need a New Procedure for the Assessment of Adverse Events in Anti-migraine Clinical Trials?
Amanzio, M. (2010) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488911794079109 · Cited by 16
Single-Dose Oral Tolerance Test with Alternative Compounds for the Management of Adverse Reactions to Drugs
Passalacqua, G., Milanese, M., Mincarini, M., Ciprandi, G., Guerra, L., Scordamaglia, A., & Canonica, G. W. (2002) · International Archives of Allergy and Immunology · doi:10.1159/000066777 · Cited by 16
Improving Medication Tolerance
Ballou, S., Iturrino, J., Rangan, V., Cheng, V., Kelley, J. M., Lembo, A. J., Kaptchuk, T. J., & Nee, J. W. (2021) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001575 · Cited by 15
Efficacy and Safety of Etanercept Biosimilars Compared With the Originator for Treatment of Juvenile Arthritis: A Prospective Observational Study
Thiele, F., Klein, A., Hospach, A., Windschall, D., Mrusek, S., Ruehlmann, J. M., & Horneff, G. (2021) · ACR Open Rheumatology · doi:10.1002/acr2.11325 · Cited by 15
The Influence of Personality on Health Complaints and Quality of Life in Women With Breast Implants
Berben, J., Miseré, R. M. L., Schop, S., & van der Hulst, R. R. (2022) · Aesthetic surgery journal · doi:10.1093/asj/sjac247 · Cited by 12
Placebo and Nocebo Responses in Pharmacological Trials of Tic Disorders: A Meta‐Analysis
Wang, S., Xiong, Z., Cui, Y., Fan, F., Zhang, S., Jia, R., Hu, Y., Li, L., Zhang, X., & Han, F. (2024) · Movement Disorders · doi:10.1002/mds.29714 · Cited by 15
Mitigating the Nocebo Effect in Biosimilar Use and Switching: A Systematic Review
Car, E., Vandenplas, Y., Lacosta, T. B., Simoens, S., Huys, I., Vulto, A. G., & Barbier, L. (2024) · Pharmaceutical Medicine · doi:10.1007/s40290-024-00541-y · Cited by 15
Morphine sulfate and naltrexone hydrochloride extended release capsules for the management of chronic, moderate-to-severe pain, while reducing morphine-induced subjective effects upon tampering by crushing
Smith, H. S. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.571205 · Cited by 15
Individual Factors Contributing to Nausea in First-Time Chemotherapy Patients: A Prospective Cohort Study
Meißner, K., Talsky, N., Olliges, E., Jacob, C., Stötzer, O. J., Salat, C., Braun, M., & Flondor, R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00410 · Cited by 15
The Nocebo Effect and Informed Consent—Taking Autonomy Seriously
Gelfand, S. (2020) · Cambridge Quarterly of Healthcare Ethics · doi:10.1017/s0963180119001026 · Cited by 15
Understanding the Placebo Effect: Part 1: Placebo Use in Clinical Trials
Howland, R. H. (2008) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20080501-06 · Cited by 15
Statin Use and Self-Reported Hindering Muscle Complaints in Older Persons: A Population Based Study
van der Ploeg, M. A., Poortvliet, R. K. E., van Blijswijk, S. C. E., den Elzen, W. P. J., van Peet, P. G., de Ruijter, W., Blom, J. W., & Gussekloo, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166857 · Cited by 15
The thinking doctor’s guide to placebos
Pittrof, R., & Rubenstein, I. (2008) · BMJ · doi:10.1136/bmj.39564.454502.c2 · Cited by 15
Placebo effects in pain
Colloca, L. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.04.001 · Cited by 15
No more than discomfort: the trauma film paradigm meets definitions of minimal-risk research
Stirling, N. S. J., Nixon, R. D. V., & Takarangi, M. K. T. (2021) · Ethics & Behavior · doi:10.1080/10508422.2021.1997603 · Cited by 14
Managing Hypercholesterolemia in Adults Older Than 75 years Without a History of Atherosclerotic Cardiovascular Disease: An Expert Clinical Consensus From the National Lipid Association and the American Geriatrics Society
Bittner, V., Linnebur, S. A., Dixon, D. L., Forman, D. E., Green, A. R., Jacobson, T. A., Orkaby, A. R., Saseen, J. J., & Virani, S. S. (2025) · Journal of the American Geriatrics Society · doi:10.1111/jgs.19398 · Cited by 15
Testing a positive-affect induction to reduce verbally induced nocebo hyperalgesia in an experimental pain paradigm
Geers, A. L., Close, S., Caplandies, F. C., Vogel, C. L., Murray, A. B., Pertiwi, Y. G., Handley, I. M., & Vase, L. (2019) · Pain · doi:10.1097/j.pain.0000000000001618 · Cited by 17
Predicting Expectations of Side-Effects for Those Which Are Warned Versus Not Warned About in Patient Information Leaflets
Webster, R., & Rubin, G. J. (2021) · Annals of Behavioral Medicine · doi:10.1093/abm/kaab015 · Cited by 14
The placebo and nocebo effects in functional urology
Mostafaei, H., Jilch, S., Carlin, G. L., Mori, K., Quhal, F., Pradère, B., Laukhtina, E., Schuettfort, V. M., Aydh, A., Motlagh, R. S., et al. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00545-2 · Cited by 14
Impact of Vaccine Hesitancy on Onset, Severity and Type of Self-reported Adverse Events: A French Cross-Sectional Survey
Khouri, C., Larabi, A., Verger, P., Gauna, F., Cracowski, J., & Ward, J. K. (2022) · Drug Safety · doi:10.1007/s40264-022-01220-0 · Cited by 14
Midodrine for the treatment of vasovagal syncope (simple FAINT)
Stewart, J. M. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.08.026 · Cited by 14
Lessons Learned From Nocebo Effects in Clinical Trials for Pain Conditions and Neurodegenerative Disorders
Amanzio, M., Palermo, S., Skyt, I., & Vase, L. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000556 · Cited by 15
The safety of treating newly diagnosed epilepsy
Sharma, S., & Kwan, P. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1602607 · Cited by 14
It is not just the drugs that matter: the nocebo effect
Wojtukiewicz, M. Z., Polityńska, B., Skalij, P., Tokajuk, P., Wojtukiewicz, A. M., & Honn, K. V. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09800-w · Cited by 15
The Role of Images on Illness Behaviour: Interdisciplinary Theory, Evidence, and Ideas
Murray, J., & Williams, B. (2020) · Psychological Reports · doi:10.1177/0033294120945602 · Cited by 13
The influence of video-based social modelling on the nocebo effect
Quinn, V. F., Pearson, S., Huynh, A., Nicholls, K., Barnes, K., & Faasse, K. (2022) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2022.111136 · Cited by 14
The safety and tolerability of beta blockers in heart failure with reduced ejection fraction: is the current underutilization of this evidence-based therapy justified?
Kiel, R. G., & DEEDWANIA, P. C. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1102225 · Cited by 13
What makes us sicker? An experimental study on non-specific adverse drug effects
Köteles, F. G., & Bárdos, G. (2011) · Clinical and Experimental Medical Journal · doi:10.1556/cemed.5.2011.4.4 · Cited by 13
Helping Children Cope With Medical Tests and Interventions
Lang, E. V., Viegas, J., Bleeker, C. P., Bruhn, J., & van Geffen, G. (2017) · Journal of Radiology Nursing · doi:10.1016/j.jradnu.2016.11.005 · Cited by 13
The impact of generic labels on the consumption of and adherence to medication: a randomized controlled trial
Goldszmidt, R. B., Buttendorf, A. R., Filho, G. S., de Souza, J. M., & Bianchini, M. A. (2018) · European Journal of Public Health · doi:10.1093/eurpub/cky183 · Cited by 13
No Reason to Feel Sick? Nocebo Responses in the Placebo Arms of Experimental Endotoxemia Studies
Benson, S., & Elsenbruch, S. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00511 · Cited by 13
Nocebo phenomena may be enhanced in aging: Implications for clinical practice
Kravvariti, E., Kotsani, M., Mitsikostas, D. D., & Sfikakis, P. P. (2020) · Maturitas · doi:10.1016/j.maturitas.2020.07.011 · Cited by 13
Attitudes toward disclosure of medication side effects: a nationwide survey of Korean patients, caregivers, and oncologists
Shin, D. W., ROTER, D. L., Cho, J., Kim, S. Y., Yang, H. K., Suh, B., Kim, Y. H., Han, J., Chung, I. J., & Park, J. H. (2015) · Psycho-Oncology · doi:10.1002/pon.3807 · Cited by 13
No blank slates: Pre-existing schemas about pharmaceuticals predict memory for side effects
Heller, M. K., Chapman, S., & Horne, R. (2017) · Psychology and Health · doi:10.1080/08870446.2016.1273355 · Cited by 12
Patient-reported allergies predict postoperative outcomes and psychosomatic markers after spine surgery
Xiong, D. D., Ye, W., Xiao, R., Miller, J. A., Mroz, T. E., Steinmetz, M. P., Nagel, S. J., & Machado, A. G. (2018) · The Spine Journal · doi:10.1016/j.spinee.2018.05.032 · Cited by 13
Nocebo and lessebo effects
Mestre, T. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.04.005 · Cited by 14
Is the increasing use of evidence‐based pharmacotherapy causing the renaissance of complementary medicine?
Vožeh, S. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2003.01879.x · Cited by 13
A Review of Side Effects and Adverse Events of Non-Drug Medicine (Nonpharmaceutical Complementary and Alternative Medicine): Psychotherapy, Mind-Body Medicine and Clinical Holistic Medicine
Ventegodt, S., & Merrick, J. (2009) · Journal of Complementary and Integrative Medicine · doi:10.2202/1553-3840.1156 · Cited by 13
Are Generic Medications Safe and Effective?
Howland, R. H. (2010) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20100204-01 · Cited by 13

Authors: Barsky, A. J.
Affiliations: Brigham and Women's Hospital (US)
Corresponding author: Barsky, Arthur J.
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2002-02-06
Volume: 287
Issue: 5
Pages: 622
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.287.5.622
OpenAlex: W2030711540
Cited by: 784
References: 69
Citations by year: 2026: 19 · 2025: 36 · 2024: 23 · 2023: 34 · 2022: 54 · 2021: 49 · 2020: 47 · 2019: 53 · 2018: 45 · 2017: 42 · 2016: 39 · 2015: 33 · 2014: 31 · 2013: 27 · 2012: 31
FWCI: 12.69
Type: journal article
Language: en
Open access: green
dash.harvard.edu
Licence: cc-by
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion)
Topics: Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords: nocebo effect, adverse drug reactions, placebo effect, patient expectations, conditioning, anxiety, depression, somatization, patient-physician communication, risk factors
MeSH terms: Attitude to Health, Drug Therapy, Humans, Negativism, Placebos, Risk Factors, Effect Modifier, Epidemiologic, Placebo Effect, Drug-Related Side Effects and Adverse Reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nonspecific Medication Side Effects and the Nocebo Phenomenon

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks